Sally Hall

Doctor of Osteopathic Medicine,  Massachusetts General Hospital 

Location: United States

Consulting Services

Research Consulting Admin and Customer Support Biostatistics

Areas Of Interest

Count, Complete Blood NSC-79037 Arabinosyladenine Chemical Shift Imaging Vitamin D Receptor Interacting Protein Complex Component DRIP205 Water Maze Test CoA Thiolase, 2-Methylacetoacetyl AP-2 beta Protein Cytokeratin 4 Cell, Erythropoietic Progenitor Lymphoma, Hodgkin's beta N Acetyl hexosaminidase Waves, High-Energy Shock Automated Facial Recognition GABA-A Receptor gamma Subunit Kimmelstiel-Wilson Disease Hydrogen Bonding Carriers, Genetic, Detection Anemia, Fanconi's beta-Galactosidase Deficiency FG9065 S-Pouchs Sequence Palindromes Developmental Coxa Valgas Fibromatosis Calmodulin Dependent Protein Kinases Disorders of Sex Development polium, Teucrium Disorder, Cerebellar Phosphorylcholine-Glyceride Transferase Agents, Immunosuppressive Body Pushers Conductometry

Professional Narrative

Dr. Sally Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Senior Director, Harvard Med 2003
Executive Director, Amgen 1993

Education

Bachelor of science in nursing, Harvard Medical School 1994
Bachelor of science in nursing, Weill Medical College 1996

Referees


Publications

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :